FMB Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$238K Sell
975
-452
-32% -$105K 0.1% 66
2025
Q4
$295K Buy
1,427
+72
+5% +$14.2K 0.12% 69
2025
Q3
$251K Sell
1,355
-10
-0.7% -$1.71K 0.11% 71
2025
Q2
$208K Sell
1,365
-40
-3% -$6.15K 0.1% 79
2025
Q1
$233K Buy
+1,405
New +$220K 0.13% 66
2024
Q4
Sell
-1,322
Closed -$214K 71
2024
Q3
$214K Buy
+1,322
New +$211K 0.12% 69
2024
Q2
Sell
-1,394
Closed -$220K 71
2024
Q1
$220K Buy
1,394
+20
+1% +$3.18K 0.18% 63
2023
Q4
$215K Buy
+1,374
New +$211K 0.2% 56
2023
Q1
Sell
-1,375
Closed -$243K 55
2022
Q4
$243K Buy
+1,375
New +$237K 0.31% 44

Other funds holding JNJ

FMB Wealth Management's JNJ Position: Q1 2026 in Review

FMB Wealth Management reduced its Johnson & Johnson (JNJ) stake by 32% in Q1 2026, selling an estimated $105K and leaving 975 shares worth $238K. The position accounts for 0.1% of the portfolio, ranked #66.

FMB Wealth Management first reported a position in JNJ in Q4 2022 and has held it in 9 quarters since. The position peaked at $295K in Q4 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • FMB Wealth Management held 975 shares of Johnson & Johnson worth $238K as of Q1 2026.
  • FMB Wealth Management sold 452 Johnson & Johnson shares in Q1 2026, an estimated $105K.
  • Johnson & Johnson made up 0.1% of FMB Wealth Management's portfolio in Q1 2026, its #66 holding.
  • FMB Wealth Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 9 quarters since.
  • FMB Wealth Management's Johnson & Johnson position peaked at $295K in Q4 2025.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on FMB Wealth Management's 13F filing for Q1 2026, filed 16 Apr 2026.